Hello
i am new to the shroom/psy-market and looking for comp. which haven`t had too much gains already. so i came across LKYSF.
lets get this in short: offering 25,367,850 Units, purchase price of $0.68 and for 2 Common Shares one warrant, exercisable until December 29, 2022 for $0.90
(+ cash commissions, Over-Allotment Options, fees. )
ADDITIONALLY the first finance with the right to buy at .35 cents expiring Sept. 10th 2022.
clearly nothing special (worse or good) just commen in this stage.
O.K. is the last offering 0,68 a normal discount to sp! warrant ex-price slightly over current valuation. Worst are the .35cent. So, everything is primed for dilution here.
( .35 .68. max sp possible .80 .90 then selling pressure, in 2022 sp at 1.20- max 1.50 for selling the last offer warrants)
I think everyone who bought in at lower prices should sell and we all wait until mid 2022? or is there anything i missed here. I am willing to learn.
I wish you all a healthy New Ear (listening is better than talking)
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM